EPO Patent Bulletin - Hybridoma Clones and Monoclonal Antibodies
Summary
The European Patent Office has published patent application EP3645042A2 concerning hybridoma clones, monoclonal antibodies to Vsig-4, and methods of making and using them. The patent is assigned to Bio-Techne Corporation and lists multiple inventors.
What changed
This document is a publication of a European Patent application (EP3645042A2) from the EPO Patent Bulletin, dated March 11, 2026. It details hybridoma clones, monoclonal antibodies targeting Vsig-4, and associated methods for their creation and application. The patent applicant is Bio-Techne Corporation.
This is a patent publication, not a regulatory rule or guidance. It does not impose new compliance obligations or deadlines on regulated entities. Its primary impact is on intellectual property rights within the pharmaceutical and biotechnology sectors, specifically concerning antibody development and therapeutic applications.
Source document (simplified)
HYBRIDOMA CLONES, MONOCLONAL ANTIBODIES TO VSIG-4, AND METHODS OF MAKING AND USING
Publication EP3645042A2 Kind: A2 Mar 11, 2026
Applicants
Bio-Techne Corporation
Inventors
AGGELER, Birte, GOETZ, Christine, BONNEVIER, Jody, VALLEY, Christopher, Carlin, HAMMERBECK, Chris, RESNIK, Ernesto Ruben
IPC Classifications
A61K 39/395 20060101AFI20210211BHEP A61P 35/00 20060101ALI20210211BHEP B82Y 30/00 20110101ALI20210211BHEP C07K 14/705 20060101ALI20210211BHEP C07K 16/28 20060101ALI20210211BHEP C12N 15/13 20060101ALI20210211BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.